Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

Brian G Feagan, Stefan Schreiber, Douglas C Wolf, Jeffrey L Axler, Arpeat Kaviya, Alexandra James, Rebecca I Curtis, Parnia Geransar, Andreas Stallmach, Robert Ehehalt, Bernd Bokemeyer, Javaria Mona Khalid, Sharon O’Byrne;Brian G Feagan;Stefan Schreiber;Douglas C Wolf;Jeffrey L Axler;Arpeat Kaviya;Alexandra James;Rebecca I Curtis;Parnia Geransar;Andreas Stallmach;Robert Ehehalt;Bernd Bokemeyer;Javaria Mona Khalid;Sharon O’Byrne;
inflammatory bowel diseases 2019 Vol. 25 pp. 1028-
353
o’byrne2019inflammatorysustained

Abstract

Sustaining clinical remission is an important treatment goal in moderate-to-severe UC. This post hoc exploratory analysis assessed the long-term efficacy of vedolizumab in the subset of patients with UC in the GEMINI 1 study who were in clinical remission ...

Keywords

Citation

ID: 116578
Ref Key: o’byrne2019inflammatorysustained
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
116578
Unique Identifier:
10.1093/ibd/izy323
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet